In musculoskeletal models, BPC-157 has consistently outperformed controls in healing timeframes for tendon transection, muscle crush injury, and bone defect models
In younger rats, the treated animals scored 24% to 35% better on tests measuring movement, coordination, and brain function
BPC 157 mitigates damaging effects, preserving neuronal structures and promoting nerve cell regeneration
It should not be presented as an approved medicine for obesity, weight management, diabetes, fatty liver disease, muscle loss, ageing or another medical condition
These experiences can vary widely due to individual differences and the specific conditions being addressed